Star Combo Pharma Ltd
ASX:S66

Watchlist Manager
Star Combo Pharma Ltd Logo
Star Combo Pharma Ltd
ASX:S66
Watchlist
Price: 0.12 AUD 9.09% Market Closed
Market Cap: 16.2m AUD
Have any thoughts about
Star Combo Pharma Ltd?
Write Note

Star Combo Pharma Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Star Combo Pharma Ltd
Accounts Receivables Peer Comparison

Comparables:
BXN
MCP
EXL
B
BIO
H
HPC

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Star Combo Pharma Ltd
ASX:S66
Accounts Receivables
AU$4.5m
CAGR 3-Years
1%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Bioxyne Ltd
ASX:BXN
Accounts Receivables
AU$978.4k
CAGR 3-Years
43%
CAGR 5-Years
5%
CAGR 10-Years
20%
McPherson's Ltd
ASX:MCP
Accounts Receivables
AU$24m
CAGR 3-Years
-14%
CAGR 5-Years
-6%
CAGR 10-Years
-9%
Elixinol Wellness Ltd
ASX:EXL
Accounts Receivables
AU$1.5m
CAGR 3-Years
14%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
B
Biome Australia Ltd
ASX:BIO
Accounts Receivables
AU$2.9m
CAGR 3-Years
57%
CAGR 5-Years
69%
CAGR 10-Years
N/A
H
Hydration Pharmaceuticals Co Ltd
ASX:HPC
Accounts Receivables
$1.7m
CAGR 3-Years
30%
CAGR 5-Years
28%
CAGR 10-Years
N/A

See Also

What is Star Combo Pharma Ltd's Accounts Receivables?
Accounts Receivables
4.5m AUD

Based on the financial report for Jun 30, 2024, Star Combo Pharma Ltd's Accounts Receivables amounts to 4.5m AUD.

What is Star Combo Pharma Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
11%

Over the last year, the Accounts Receivables growth was 4%. The average annual Accounts Receivables growth rates for Star Combo Pharma Ltd have been 1% over the past three years , 11% over the past five years .

Back to Top